Compare BKTI & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BKTI | ENLV |
|---|---|---|
| Founded | 1997 | 2005 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 284.7M | 249.3M |
| IPO Year | N/A | 1995 |
| Metric | BKTI | ENLV |
|---|---|---|
| Price | $75.23 | $1.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $74.00 | $13.00 |
| AVG Volume (30 Days) | 44.4K | ★ 466.2K |
| Earning Date | 11-06-2025 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 136.69 | N/A |
| EPS | ★ 3.30 | N/A |
| Revenue | ★ $82,558,000.00 | N/A |
| Revenue This Year | $12.00 | N/A |
| Revenue Next Year | $11.30 | N/A |
| P/E Ratio | $23.31 | ★ N/A |
| Revenue Growth | ★ 10.12 | N/A |
| 52 Week Low | $26.20 | $0.66 |
| 52 Week High | $89.23 | $2.10 |
| Indicator | BKTI | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 46.21 | 57.04 |
| Support Level | $74.46 | $0.99 |
| Resistance Level | $80.83 | $1.26 |
| Average True Range (ATR) | 3.96 | 0.08 |
| MACD | -1.11 | 0.00 |
| Stochastic Oscillator | 18.79 | 46.63 |
BK Technologies Corp a holding company, operates through its subsidiary, BK Technologies, Inc., specializing in designing, manufacturing, and marketing wireless communications equipment. Its Radio business unit offers two-way land mobile radios (LMRs) serving government and public safety markets, as well as industrial and commercial enterprises. The SaaS business unit focuses on public safety smartphone applications, enhancing first responders' safety and efficiency. The BKRplay application, tethered to BK radios, amplifies user capabilities, expanding the reach of their radio sales. Its product portfolio consists of two-way land mobile radios, handheld radios, radios installed in vehicles.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.